Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
2017 Standout
Infective Endocarditis
2005 Standout
Facts and Controversies in Systemic Treatment of Metastatic Breast Cancer
2004
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies
2006
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
2002
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
Risk Factors and Predictors of Outcome in Patients with Cancer and Breakthrough Candidemia
2001
Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines
2019
Viridans Group Streptococcal Infections Among Children With Cancer and the Importance of Emerging Antibiotic Resistance
2006
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia
2007
Candidemia in a Tertiary Care Cancer Center
2003
Role of Gemcitabine in Breast Cancer Management: An Update
2006
Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres
2005
Current Trends in the Epidemiology of Nosocomial Bloodstream Infections in Patients with Hematological Malignancies and Solid Neoplasms in Hospitals in the United States
2003
Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients
2007
Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: A meta-analysis
2008
Review of the Incidence and Prognosis of Pseudomonas aeruginosa Infections in Cancer Patients in the 1990s
2000
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
2007 Standout
Disseminated Zygomycosis in a Neutropenic Patient: Successful Treatment with Amphotericin B Lipid Complex and Granulocyte Colony-Stimulating Factor
1997
In Vivo Pathogenicity of Eight Medically Relevant Candida Species in an Animal Model
2002
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Infective Endocarditis Due to Penicillin-Resistant Viridans Group Streptococci
2007
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
Candida lusitaniae: A Cause of Breakthrough Fungemia in Cancer Patients
2001
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
2003
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Epothilones in the treatment of cancer
2006
1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
1997
Factors associated with candiduria and related mortality
2007
Echinocandin antifungal drugs
2003 Standout
The central nervous system and infection by Candida species
2000
Infections due to emerging and uncommon medically important fungal pathogens
2004
Candiduria in haematologic malignancy patients without a urinary catheter: nothing more than a frailty marker?
2012
Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment
2004
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
2006
GRADE guidelines 6. Rating the quality of evidence—imprecision
2011 Standout
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Epidemiology, treatment and outcome of candidemia: a five‐year review at three Canadian hospitals
2002
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
2010 Standout
Trends in species causing fungaemia in a tertiary care medical centre over 12 years
2001
Microbiota: a key orchestrator of cancer therapy
2017
Multiple-Treatments Meta-analysis of Chemotherapy and Targeted Therapies in Advanced Breast Cancer
2008
Antifungal Agents. Part I. Amphotericin B Preparations and Flucytosine
1998
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Two Cases of Fungemia due to Candida lusitaniae and a Literature Review
2002
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
2018 Standout
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences
2002
Candidemia in Allogeneic Blood and Marrow Transplant Recipients: Evolution of Risk Factors after the Adoption of Prophylactic Fluconazole
2000
Possible Role of Catheters in Saccharomyces boulardii Fungemia
2000
Successful ceftriaxone therapy of endocarditis due to penicillin non-susceptible viridans streptococci
2006
Immunity to fungal infections
2011 Standout
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
2007 Standout
Candida lusitaniaeInfections in the Era of Fluconazole Availability
2003
Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomes
2011
-D-Glucan as a Diagnostic Adjunct for Invasive Fungal Infections: Validation, Cutoff Development, and Performance in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome
2004
Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections
2004
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
2002 Standout
Emerging and less common fungal pathogens
2002
Fluconazole
1995
Antimicrobial Susceptibility Patterns among Viridans Group Streptococcal Isolates from Infective Endocarditis Patients from 1971 to 1986 and 1994 to 2002
2004
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Candida Infections of Medical Devices
2004 Standout
A comparison of different antibiotic regimens for the treatment of infective endocarditis
2016
Zygomycetes in Human Disease
2000 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
2005
TLR4 and Toll-IL-1 Receptor Domain-Containing Adapter-Inducing IFN-β, but Not MyD88, RegulateEscherichia coli-Induced Dendritic Cell Maturation and Apoptosis In Vivo
2005
Current and Emerging Azole Antifungal Agents
1999 Standout
Antifungal prophylaxis during neutropenia and immunodeficiency
1997
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy
2012
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Invasive Candidiasis
2015 Standout
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
2012 Standout
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
2016
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Reappraisal With Meta-Analysis of the Addition of Gram-Positive Prophylaxis to Fluoroquinolone in Neutropenic Patients
2003
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Prosthetic Joint Infection
2014 Standout
Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
2004
Geographic Variation in the Susceptibilities of Invasive Isolates of Candida glabrata to Seven Systemically Active Antifungal Agents: a Global Assessment from the ARTEMIS Antifungal Surveillance Program Conducted in 2001 and 2002
2004
Guidelines for Treatment of Candidiasis
2004 Standout
Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients
2005
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
Community-acquired anaerobic bacteremia in adults: one-year experience in a medical center.
2005
Multiple Antibiotic Resistance in Stenotrophomonas maltophilia : Involvement of a Multidrug Efflux System
2000
Works of S. Špánik being referenced
Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case-controlled study
1999
Invasive mold infections in cancer patients: 5 years' experience withAspergillus, Mucor, Fusarium andAcremonium infections
1996
Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol
1999
Analysis of 553 episodes of monomicrobial bacteraemia in cancer patients: any association between risk factors and outcome to particular pathogen?
1997
Bacteremia Due to Multiresistant Gram-Negative Bacilli in Neutropenic Cancer Patients: A Case Controlled Study
1998
Candida glabrata fungemia in a tertiary cancer institution in Slovakia
1999
Fungemia in Cancer Patients Undergoing Chemotherapy Versus Surgery: Risk Factors, Etiology and Outcome
1997
Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study
2015
Bacteremia due to methicillin-resistant staphylococci occurs more frequently in neutropenic patients who received antimicrobial prophylaxis and is associated with higher mortality in comparison to methicillin-sensitive bacteriemia
1998
Funguria in cancer patients: Analysis of risk factors, clinical presentation and outcome in 50 patients
1996
Do Vancomycin Serum Levels Predict Failures of Vancomycin Therapy or Nephrotoxicity in Cancer Patients?
1997
Breakthrough Fungemia Appearing during Empiric Therapy with Amphotericin B
1997
Predictors of mortality in bacteremic cancer patients: retrospective analysis of 64 deaths occurring among 262 bacteremic episodes
1998
Bacteremias caused by Escherichia coli in cancer patients — analysis of 65 episodes
2002
<i>Candida</i><i>glabrata</i>, <i>Candida</i><i>krusei</i>, Non-albicans <i>Candida</i> spp., and Other Fungal Organisms in a Sixty-Bed National Cancer Center in 1989-1993: No Association with the Use of Fluconazole
1995
Netilmicin plus Ceftriaxone versus Amikacin plus Ceftriaxone in the Treatment of Infections in Granulocytopenic Patients
1992
Fluconazole in the Treatment of Mycotic Oropharyngeal Stomatitis and Esophagitis in Neutropenic Cancer Patients
1991
Eight-Year Surveillance of Non-Albicans Candida spp . in an Oncology Department Prior to and After Fluconazole Had Been Introduced into Antifungal Prophylaxis
1997
Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome
1998
Viridans Streptococcal Bacteraemia Due to Penicillin-Resistant and Penicillin-Sensitive Streptococci: Analysis of Risk Factors and Outcome in 60 Patients from a Single Cancer Centre Before and After Penicillin is Used for Prophylaxis
1997
Amphotericin B Lipid Complex to Treat Invasive Fungal Infections in Cancer Patients: Report of Efficacy and Safety in 20 Patients
1995
Fungaemia due to Fusarium spp. in cancer patients
1997
NosocomialCandida kruseiFungemia in Cancer Patients: Report of 10 Cases and Review
1999
Inappropriate antibiotic therapy in febrile cancer patients with bacteremia.
1998
Bloodstream infections due to anaerobic bacteria in cancer patients: epidemiology, etiology, risk factors, clinical presentation and outcome of anaerobic bacteremia.
1996
Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer
2013
Imipenen-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome.
1996
Candida parapsilosis fungemia in cancer patients--incidence, risk factors and outcome.
1998
Gemcitabine, Epirubicin, and Paclitaxel Versus Fluorouracil, Epirubicin, and Cyclophosphamide As First-Line Chemotherapy in Metastatic Breast Cancer: A Central European Cooperative Oncology Group International, Multicenter, Prospective, Randomized Phase III Trial
2005
Phase I/II dose-escalation trial of patupilone every 3 weeks in patients with relapsed/refractory ovarian cancer
2005
Etiology, Risk Factors and Outcome of 1003 Cases of Infective Endocarditis from a 33-year National Survey in the Slovak Republic: An increasing proportion of elderly patients.
2019
Bacteremia in neutropenic versus nonneutropenic cancer patients: etiology and outcome in 401 episodes.
1997